TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — Net Income

Annual figures by fiscal year, from SEC filings.

2015: -$4.61M2016: -$14.07M2017: -$29.08M2018: -$74.16M2019: -$95.18M2020: -$255.57M2021: -$73.33M2022: -$23.21M2023: -$28.45M2024: -$39.83M2025: -$26.48M-$26.48M
2015Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$26.48M+33.5%
2024-$39.83M-40.0%
2023-$28.45M-22.6%
2022-$23.21M+68.3%
2021-$73.33M+71.3%
2020-$255.57M-168.5%
2019-$95.18M-28.3%
2018-$74.16M-155.1%
2017-$29.08M-106.7%
2016-$14.07M-205.3%
2015-$4.61M—